Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von fchar99 

Insmed Inc. diskutieren

Insmed Inc.

WKN: A1JJA3 / Symbol: INSM / Name: Insmed / Aktie / Biotechnologie & medizinische Forschung / Small Cap /

120,00 €
-1,64 %

Insmed (NASDAQ:INSM) was upgraded by analysts at Roth Mkm to a "strong-buy" rating.
Ratings data for INSM provided by MarketBeat

Einschätzung Buy
Rendite (%) -9,35 %
Kursziel 194,44
Veränderung
Endet am 23.02.27

Insmed (NASDAQ:INSM) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $230.00 price target on the stock.
Ratings data for INSM provided by MarketBeat

Einschätzung Buy
Rendite (%) -6,67 %
Kursziel 173,11
Veränderung
Endet am 24.02.27

Insmed (NASDAQ:INSM) had its price target lowered by analysts at Mizuho from $211.00 to $204.00. They now have an "outperform" rating on the stock.
Ratings data for INSM provided by MarketBeat

Insmed (INSM) is now covered by Jefferies Financial Group Inc.. They set a "buy" rating on the stock.
Ratings data for INSM provided by MarketBeat